Cidara Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 201-225 of 798 matching filings.

Per page
25
Current page
9
PRE 14A File 001-36912

PRELIMINARY PROXY STATEMENT

Filing date
23 May 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
20 May 2024
Reporting date
14 May 2024
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
15 May 2024
Reporting date
15 May 2024
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
15 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
D File 021-512417

D filing

Filing date
06 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
03 May 2024
Reporting date
03 May 2024
Next action
Verify source filing
4

4 filing

Filing date
30 Apr 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Apr 2024
Reporting date
24 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Apr 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
30 Apr 2024
Reporting date
24 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Apr 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
30 Apr 2024
Reporting date
24 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Apr 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
30 Apr 2024
Reporting date
24 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K/A

Filing date
29 Apr 2024
Reporting date
23 Apr 2024
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
24 Apr 2024
Reporting date
23 Apr 2024
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
24 Apr 2024
Reporting date
23 Apr 2024
Next action
Verify source filing
S-8 File 333-278872

CIDARA THERAPEUTICS, INC. FORM S-8

Filing date
23 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
22 Apr 2024
Reporting date
22 Apr 2024
Next action
Verify source filing
10-K File 001-36912

CIDARA THERAPEUTICS, INC. 2023 FORM 10-K

Filing date
22 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
16 Apr 2024
Reporting date
11 Apr 2024
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
05 Apr 2024
Reporting date
04 Apr 2024
Next action
Verify source filing
NT 10-K File 001-36912

NOTIFICATION OF LATE FILING

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2024
Reporting date
15 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2024
Reporting date
15 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .